Filing Details

Accession Number:
0001179110-14-017218
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-26 16:50:21
Reporting Period:
2014-11-25
Filing Date:
2014-11-26
Accepted Time:
2014-11-26 16:50:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274057 Hospira Inc HSP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617306 J Marc Yoskowitz C/O Hospira, Inc.
275 North Field Drive
Lake Forest IL 60045
Svp, Strategy & Corporate Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-25 11,523 $37.36 43,146 No 4 M Direct
Common Stock Disposition 2014-11-25 11,523 $59.93 31,623 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Acquisiton 2014-11-25 11,523 $0.00 11,523 $37.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,570 2020-06-28 No 4 M Direct
Footnotes
  1. Exercise of derivative security exempted pursuant to Rule 16b-3.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.91 to $59.94, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
  3. The stock options, granted on June 28, 2013, vest in four equal annual installments on June 28, 2014, 2015, 2016, and 2017. The exercise price of $37.36 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on June 28, 2020.